APP
CMD

Avantax Planning Partners’s Cantel Medical Corporation CMD Stock Holding History

Avantax Planning Partners’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-53
Closed -$5K – 1683
2018
Q1 		$5K Buy
+53
New +$5.94K ﹤0.01% 1379

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Avantax Planning Partners's CMD Position: Q2 2018 in Review

Avantax Planning Partners sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 53 shares — an estimated $5K sold.

Avantax Planning Partners first reported a position in CMD in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Avantax Planning Partners reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 53 Cantel Medical Corporation shares in Q2 2018, an estimated $5K.
  • Avantax Planning Partners first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 1 quarter.
  • Avantax Planning Partners's Cantel Medical Corporation position peaked at $5K in Q1 2018.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.